Las Vegas Review-Journal, October 6, 2011 A jury found three drug companies liable Thursday for the infections of three former patients at the clinics linked to Southern Nevada’s hepatitis C outbreak. (Robert Eglet featured in article.)
News
Jury Told Teva Puts Its Profit Ahead of Propofol Patient Safety
Bloomberg, October 5, 2011 Teva Pharmaceutical Industries Ltd. (TEVA), the world’s biggest generic-drug maker, was accused by lawyers at a Nevada trial of putting profit ahead of the safety of colonoscopy patients who got the company’s Propofol anesthetic from reused vials. (Robert Eglet featured in article. Photo credit: Las Vegas Review-Journal)
Defense Witness in Second Hepatitis C Trial in Nevada, Dr. Arthur Reingold, Testimony on Plausible Cause for Contamination Impeached
PR Newswire , October 1, 2011 Dr. Arthur Reingold, witness for the defense in the second hepatitis C trial in Nevada, was called to the stand today offering expert testimony as an epidemiologist.
Eglet Law is Proud to Support the MDA (Muscular Dystrophy Association)
September 2, 2011 — Eglet Law is Proud to Support the MDA (Muscular Dystrophy Association). For the past 61 years, the MDA has helped millions of individuals who suffer from neuromuscular diseases. Through the annual MDA Labor Day Telethon and other local fundraising projects, the MDA is able to fund worldwide research, clinics, summer camps, education […]
